Hung Chang

11PUBLICATIONS
18CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical biochemistry - proteins and peptides (incl. medical proteomics)Immunogenetics (incl. genetic immunology)AutoimmunityPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Sep 29, 2026
Safe and effective rechallenge of zanubrutinib in combination with obinutumumab in follicular lymphoma after severe drug-induced liver injury.

|Sep 09, 2026
Hyperpolarized 13C Pyruvate MRI/MRS for Characterizing Splenic Metabolism in Advanced Diffuse Large B-Cell Lymphoma: A Pilot Study.

|Jun 19, 2026
β2-microglobulin is superior to lactate dehydrogenase and bulky disease for risk stratification in diffuse large B-cell lymphoma patients with IPI 1-2.

|Jun 30, 2025
Risk factors and clinical consequences of rituximab infusion-related reactions.

Chi-Hsiang Hou, Hung Chang, Yuen-Chin Ong

|Mar 20, 2025
Prognostic impact of pre-treatment and post-treatment plasma Epstein-Barr virus DNA in peripheral T-cell lymphomas.

Chu-Yi Chan, Tung-Liang Lin, Ming-Chung Kuo

|Feb 09, 2022
Changing profile of platelet activity and turnover indices during treatment response of immune thrombocytopenia.

Chewei Ou, Hung Chang, Yu-Shin Hung

Pageof 2

Frequent Collaborators

2 joint publications

Lee-Yung Shih

2 joint publications

Wen-Yu Chuang

1 joint publications

Chu-Yi Chan

1 joint publications

Tung-Liang Lin